Kintara Therapeutics Inc - Rasio nilai perusahaan marang dodolan KTRA

Simbol resmi perusahaan kintara.com (KTRA)

Kintara Therapeutics (KTRA) is building a unique pipeline of treatments to combat rare brain tumors. The preparation of final molecular tests relies on the services of external CRO partners. The EV-to-revenue multiple demonstrates the enterprise value, where the current level is 0.00. Meanwhile, the business operates on a virtual model, fully delegating chemical filling and research to third-party CMO laboratories.

Kintara Pharma (KTRA): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Kintara - rincian analitis lan metrik utama (KTRA)

- data saldo dhuwit lan arus kas:
Pambiji fundamental perusahaan:KTRA, kintara.com
Produk sing diprodhuksi Kintara Therapeutics Inc

To identify the fundamental drivers of stability for Kintara Therapeutics (KTRA), one should analyze the Enterprise Value to revenue ratio, which eliminates the impact of debt load and reflects the actual market price per unit of sales. The valuation trend of the enterprise via EV/Sales allows for an assessment of the capitalization potential of Kintara Therapeutics, considering the scalability of antitumor drug synthesis and the low cost of their mass production.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan Cellectar CLRB|BLRX (BioLineRx) - Nilai perusahaan marang volume dodolan|CANF: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan aprea.com|Kazia Therapeutics Limited (KZIA) - Rasio nilai perusahaan marang pendapatan|SLXN - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan NCNA|CMRX: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CYCC|Nilai perusahaan marang pendapatan g1therapeutics.com GTHX|Rasio nilai perusahaan marang pendapatan Kronos Bio, Inc. KRON|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales